Advertisement

Topics

Latest "Level Brands, Inc." News Stories

07:43 EST 20th January 2019 | BioPortfolio

Here are the most relevant search results for "Level Brands, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Level Brands, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Level Brands, Inc. for you to read. Along with our medical data and news we also list Level Brands, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Level Brands, Inc. Companies for you to search.

Showing "Level Brands" News Articles 1–25 of 6,000+

Sunday 20th January 2019

Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018" provides an overview of Acute Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Spinal Cord Injury. Report includes an overview of trial numbers and their a...


Saturday 19th January 2019

Anterior Uveitis Global Clinical Trials Review, H2, 2018 [Report Updated: 31102018] Prices from USD $2500

Anterior Uveitis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Anterior Uveitis Global Clinical Trials Review, H2, 2018" provides an overview of Anterior Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Anterior Uveitis. Report includes an overview of trial numbers and their average enrollment in top countri...

Wilms' Tumor Nephroblastoma Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

Wilms' Tumor Nephroblastoma Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Wilms' Tumor Nephroblastoma Global Clinical Trials Review, H2, 2018" provides an overview of Wilms' Tumor Nephroblastoma clinical trials scenario. This report provides top line data relating to the clinical trials on Wilms' Tumor Nephroblastoma. Report includes an overview of trial numbers...


Is ayurveda losing way to modern medicine?

Ayurveda, the Indian ethnomedicine, has gained substantial importance in recent times at international level.

How have pharmaceutical innovation affected mortality in the Middle East and Africa?

Although the high cost of pharmaceuticals is often in the news, these costs are offset by improved health benefits. However, it may not be clear the extent to which new pharmaceutical products lead to improved health at the national level. A paper by Lichtenberg (2018) aims to examine this question looking at the introduction of…

Friday 18th January 2019

CHINA AID, the Key Gateway to the Chinese Elderly Care Market, to Take Place in Shanghai in 2019

SHANGHAI, Jan. 18, 2019 /PRNewswire/ -- CHINA AID 2019, hosted by Shanghai Intex Exhibition Co., Ltd., is taking place from Wednesday 11th to Friday 13th June 2019 at the Shanghai New International Expo Centre (SNIEC) in Pu Dong, Shanghai. By the end of 2017, the number of seniors in China over the age of 60 surpassed 241 million, accounting for 17.3 percent of the country's total population. The...

Are radiology reports too difficult for patients to understand?

Although online portals allow some patients to easily access their radiology reports, new research published Jan. 8 in the American Journal of Roentgenology found that lumbar spine MRI reports in particular are written at a reading level too advanced for the average patient to comprehend.

Vulnerable Micro-Preemie Given Second Chance at Life Thanks to Volunteers’ Gift of Touch

El Camino Hospital team recognized for volunteering almost 600 hours to nurture baby in critical first weeks; today she’s 15 months old and has been adopted Five incredible California women were recognized this week for the almost 600 hours they volunteered to give one micro-preemie the gift of touch she needed to survive, develop and grow during the...

How VSP Global Drives Growth and Impact Through Purpose

Having a clearly defined purpose that goes beyond generating shareholder profits is essential to thriving in today’s market. Consumers actively support brands that share their beliefs. Plus, purpose provides an insightful compass to navigate brand strategy and business decisions.

Hire a 'Burnout' Officer to Help Physicians: Report

A new report calls for all major healthcare organizations to have an executive-level chief wellness officer tasked with reducing physician burnout. Medscape Medical News

Compulink Showcases SMART Ophthalmology EHR Solution at Hawaiian Eye 2019

Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will demonstrate its ophthalmology-specific system,

#VisualAbstract: Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction The ARTEMIS Randomized Clinical Trial

1. In this randomized controlled trial, medication vouchers were associated with a small increase in patient-reported persistence with P2Y12 inhibitors for patients who had suffered a myocardial infarction (MI). 2. Medication vouchers were not associated with reduced major adverse cardiovascular events (MACE) in these patients. Evidence Rating Level: 1 (Excellent)       Study Rundown: Anti...

WiskottAldrich Syndrome Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

WiskottAldrich Syndrome Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, WiskottAldrich Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of WiskottAldrich Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on WiskottAldrich Syndrome. Report includes an overview of trial numbers and their avera...

Overlake Medical Center and EvergreenHealth Participating in Trial to Enhance Mothers’ Childbirth Experience and Safety

Quality improvement program aims to reduce C-sections and increase adherence to birth plans EvergreenHealth and Overlake Medical Center announced today that they are collaborating as two of only four hospitals in the country partnering with Ariadne Labs—a joint center of Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health...

Teleflex to Showcase the MANTA™ Vascular Closure Device from the Recently Acquired Essential Medical, Inc. at the Annual Meeting of the Leipzig Interventional Course (LINC) 2019, in Leipzig, Germany, on January 22-25

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies with solutions in the fields of vascular and interventional access, surgical and cardiac care, will showcase the MANTA™ Vascular Closure Device as well as its portfolio for peripheral interventions at the Annual Meeting of the Leipzig Interventional Course (LINC) 2019, in ...

Arev Brands acquires land plots for cultivation in Sorrento, British Columbia

The two rural properties in Sorrento, BC are being prepared for the cultivation of medicinal plants

Arev Brands strikes C$1.2M deal to clinch Canna Gold's assets

Thanks to the acquisition, Arev now has a complete cannabis portfolio, ranging from seeds to high-quality extract and concentrates for use in its finished products

EMA continues to be open to alternative clinical development strategies for biosimilars

In the European Union (EU) and other highly regulated markets, companies need to prove the similarity of proposed biosimilars to the established reference product for gaining market authorization. European regulators recommend using a step-wise approach whose first steps consist of a demonstration of similarity at the analytical level and via non-clinical studies. In addition, as a later step, cli...

How high will Manchester United can finish? | Football News – SkySports

How high will Manchester United can finish? | Football News SkySportsJose Mourinho: Ex-Manchester United manager is 'too young to retire' & 'belongs at top level' BBC SportJosé Mourinho: player power gone too far | Sport The TimesPaul Pogba says Manchester United have rediscovered identity under Ole Gunnar Solskjaer SkySportsMan Utd news: Players and staff want Solskjaer as perm...

Proposed Classification for Health Information Systems: Provider and Individual

Recent events and some of my recent blog notes have caused me to question whether we need a new, high-level classification that encompasses all health information systems. I am going to give this idea a try. The goal of such a large scale systematic plan is to understand the functionality...

Manchester United could risk missing out on potential managerial targets – Manchester Evening News

Manchester United could risk missing out on potential managerial targets Manchester Evening NewsJose Mourinho: Ex-Manchester United manager is 'too young to retire' & 'belongs at top level' BBC SportPaul Pogba says Manchester United have rediscovered identity under Ole Gunnar Solskjaer SkySportsJose Mourinho gives verdict as Man Utd search for sporting director to work over next boss Expre...

Thursday 17th January 2019

Agoraphobia Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

Agoraphobia Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Agoraphobia Global Clinical Trials Review, H2, 2018" provides an overview of Agoraphobia clinical trials scenario. This report provides top line data relating to the clinical trials on Agoraphobia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across ...

Urticaria Pigmentosa Mastocytosis, Mastocytoma Global Clinical Trials Review, H2, 2018 [Report Updated: 28092018] Prices from USD $2500

Urticaria Pigmentosa Mastocytosis, Mastocytoma Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Urticaria Pigmentosa Mastocytosis, Mastocytoma Global Clinical Trials Review, H2, 2018" provides an overview of Urticaria Pigmentosa Mastocytosis, Mastocytoma clinical trials scenario. This report provides top line data relating to the clinical trials on Urticaria Pigmen...

New technologies enable better-than-ever details on genetically modified plants

(Salk Institute) Salk researchers have mapped the genomes and epigenomes of genetically modified plant lines with the highest resolution ever to reveal exactly what happens at a molecular level when a piece of foreign DNA is inserted. Their findings, published in the journal PLOS Genetics on January 15, 2019, elucidate the routine methods used to modify plants, and offer new ways to more effective...

New DNA sequencer installed at Harry Perkins Institute

The Harry Perkins Institute of Medical Research (HPIMR) has installed an Illumina NovaSeq 6000 DNA sequencer as part of the Australian Cancer Research Foundation (ACRF) Centre for Advanced Cancer Genomics. The sequencer will be housed at the single-cell sequencing facility being led by Professor Alistair Forrest at the HPIMR, on behalf of a consortium of cancer researchers from across Perth. Las...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks